Response to Oral Immediate‐Release Opioids for Breakthrough Pain in Patients With Advanced Cancer With Adequately Controlled Background Pain

Oncologist- United States

doi 10.1634/theoncologist.2017-0583

Full Text

Abstract

Available in

Categories

Cancer Research

Date

September 25, 2018

Authors

Vishidha R. Balankari

Margeaux Chiou Epner

Susan E. Frisbee‐Hume

Publisher

Alphamed Press

Related search

Evidence-Based Treatment of Cancer-Related Breakthrough Pain With Opioids

Journal of the National Comprehensive Cancer Network : JNCCN

English

Heart Rate Variability During Treatment of Breakthrough Pain in Patients With Advanced Cancer: A Pilot Study

Journal of Pain Research

English

Safety Profile of Prophylactic Rescue Dosing of Immediate-Release Oral Opioids in Cancer Patients

Journal of Pharmaceutical Health Care and Sciences

English

Nitrous Oxide/Oxygen Mixture for Analgesia in Adult Cancer Patients With Breakthrough Pain: A Randomized, Double-Blind Controlled Trial

European Journal of Pain

English

Opioids for Chronic Non-Cancer Pain

British Medical Journal

English

Opioids for Chronic Non-Cancer Pain

English

Cost-Effectiveness Analysis of Oral Fentanyl Formulations for Breakthrough Cancer Pain Treatment

Value in Health

Occupational Health

English

Intravenous Opioids in Chronic Cancer Pain.

English

Role of Intranasal Fentanyl in Breakthrough Pain Management in Cancer Patients

Cancer Management and Research

English